Group 1: Market Overview - 22 stocks had a closing order amount exceeding 1 billion yuan, with Tianyu Shuke leading at 2.95 billion yuan [2] - The top three stocks by closing order volume were Jihua Group, Tianyu Shuke, and Jishi Media, with volumes of 418,600 hands, 396,600 hands, and 323,700 hands respectively [2] - Stocks with consecutive limit-up days included *ST Dongjing and *ST Yushun with 5 consecutive days, while Beiwai Technology, Furi Electronics, and Guoji Precision achieved 4 consecutive days [2] Group 2: Company Performance - Tianyu Shuke is expected to achieve a net profit attributable to shareholders of 18 million to 26 million yuan in the first half of the year, marking a turnaround from losses [2] - The company reported growth in data traffic business and implemented cost-reduction measures positively impacting performance [2] - Ningbo Yunsheng anticipates a net profit of 90 million to 135 million yuan for the first half of 2025, representing a year-on-year growth of 133.55% to 250.33% [3] Group 3: Industry Insights - The rare earth permanent magnet sector saw stocks like Zhenghai Magnetic Materials and Ningbo Yunsheng hitting the limit-up [3] - The semiconductor sector had stocks such as Fumanwei and Dongxin Co. also reaching limit-up, with Fumanwei confirming normal shipments of 5G RF chips [4][5] - The brain-computer interface sector is indirectly engaged by companies like Jihua Group and Innovation Medical through partnerships, although they do not directly develop the technology [6] Group 4: Investment Trends - The top net buying stocks on the Dragon and Tiger list included Shuo Beid, Dongxin Peace, and Lide Man, with net buying amounts of 533 million yuan, 245 million yuan, and 214 million yuan respectively [7] - Institutional net buying was led by Dongfang Precision and Dawi Co., with amounts of 161 million yuan and 57.87 million yuan respectively [7]

Group 1 - The stock of Innovation Medical reached the daily limit, with a turnover rate of 30.10% and a transaction amount of 2.05 billion yuan, showing a fluctuation of 11.20% [2] - Institutional investors net sold 109 million yuan, while brokerage seats collectively net bought 136 million yuan [2] - The stock was listed on the Shenzhen Stock Exchange's daily limit deviation list due to a deviation of 10.05% [2] Group 2 - The top five brokerage seats accounted for a total transaction of 454 million yuan, with a buying amount of 241 million yuan and a selling amount of 213 million yuan, resulting in a net buying of 27.19 million yuan [2] - Among the brokerage seats, four institutional special seats were involved, with a total buying amount of 75.62 million yuan and a selling amount of 185 million yuan, leading to a net sell of 109 million yuan [2] - Over the past six months, the stock has appeared on the daily limit list seven times, with an average price drop of 0.68% the next day and an average increase of 0.65% over the following five days [2] Group 3 - The stock saw a net inflow of 226 million yuan from main funds today, with a significant single net inflow of 211 million yuan and a large single fund inflow of 15.46 million yuan [2] - In the past five days, the main funds have seen a net inflow of 398 million yuan [2]

资金面上看，今日脑机接口概念板块获主力资金净流入4.21亿元，其中，17股获主力资金净流入，6股 主力资金净流入超3000万元，净流入资金居首的是际华集团，今日主力资金净流入3.88亿元，净流入资 金居前的还有创新医疗、汉威科技、三博脑科等，主力资金分别净流入2.26亿元、5017.95万元、 4944.78万元。 截至8月7日收盘，脑机接口概念上涨2.69%，位居概念板块涨幅第2，板块内，27股上涨，际华集团、 创新医疗等涨停，倍益康、翔宇医疗、爱朋医疗等涨幅居前，分别上涨17.75%、11.74%、8.45%。跌幅 居前的有谱尼测试、普利特、均普智能等，分别下跌1.77%、1.75%、1.68%。 今日涨跌幅居前的概念板块 | 概念 | 今日涨跌幅（%） | 概念 | 今日涨跌幅（%） | | --- | --- | --- | --- | | 稀土永磁 | 3.24 | 减肥药 | -1.70 | | 脑机接口 | 2.69 | CRO概念 | -1.66 | | 高压氧舱 | 2.56 | 创新药 | -1.41 | | 太赫兹 | 1.65 | 仿制药一致性评价 | -1.34 | | 血氧仪 | ...

Group 1 - The high-pressure oxygen chamber concept increased by 2.56%, ranking third among concept sectors, with five stocks rising, including Innovation Medical which hit the daily limit, and others like BeiYikang, Jinling Pharmaceutical, and Yingkang Life showing gains of 17.75%, 3.79%, and 1.25% respectively [1][2] - The main funds net inflow into the high-pressure oxygen chamber concept was 239 million yuan, with Innovation Medical receiving the highest net inflow of 226 million yuan, followed by Jinling Pharmaceutical and Yingkang Life with net inflows of 41.83 million yuan and 6.52 million yuan respectively [2][3] - The net inflow ratios for Innovation Medical, Jinling Pharmaceutical, and Yingkang Life were 11.04%, 8.08%, and 4.30% respectively, indicating strong investor interest in these stocks [3] Group 2 - The top gainers in the high-pressure oxygen chamber concept included Innovation Medical, Jinling Pharmaceutical, and Yingkang Life, while the top losers were Weiao Co., Samsung Medical, and Tiejian Heavy Industry, with declines of 1.74%, 0.92%, and 0.69% respectively [1][4] - The trading volume and turnover rates for the leading stocks in the high-pressure oxygen chamber concept were significant, with Innovation Medical showing a turnover rate of 30.10% and a trading volume of 22.62 million yuan [3]

沪指8月7日上涨0.16%，申万所属行业中，今日上涨的有18个，涨幅居前的行业为有色金属、美容护 理，涨幅分别为1.20%、0.99%。跌幅居前的行业为医药生物、电力设备，跌幅分别为0.92%、0.74%。 医药生物行业位居今日跌幅榜首位。 | 代码 | 简称 | 今日涨跌幅（%） | 今日换手率（%） | 主力资金流量（万元） | | --- | --- | --- | --- | --- | | 688166 | 博瑞医药 | -5.70 | 3.89 | 23275.85 | | 002173 | 创新医疗 | 10.01 | 30.10 | 22618.18 | | 000710 | 贝瑞基因 | 5.26 | 23.64 | 20015.67 | | 300289 | 利德曼 | 20.02 | 21.71 | 17141.65 | | 002022 | 科华生物 | 9.96 | 12.63 | 15290.70 | | 300981 | 中红医疗 | 19.99 | 8.06 | 11833.89 | | 300760 | 迈瑞医疗 | 1.09 | 0.60 | 11395.45 | | 00 ...

证券之星消息，截至2025年8月7日收盘，创新医疗(002173)报收于17.47元，上涨10.01%，涨停，换手率 30.1%，成交量125.3万手，成交额20.5亿元。 8月7日的资金流向数据方面，主力资金净流入1.88亿元，占总成交额9.15%，游资资金净流出1.2亿元， 占总成交额5.84%，散户资金净流出6795.37万元，占总成交额3.32%。 近5日资金流向一览见下表： | | | | | 日期 收盘价 涨跌幅 主力净流入 主力净占比 游资净流入 游资净占比 散户净占比 | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 2025-08-07 | 17.47 10.01% | | 1.88亿 | 9.15% | -1.20亿 | -5.84% | -6795.37万 | -3.32% | | 2025-08-06 | 15.88 | -2.16% | -1.65 亿 | -9.77% | -4099.22万 | -2.43% | 2.06亿 | 12.20% | | 2025-08-05 | 16.23 10.0 ...

8月6日，医疗服务行业下跌0.87%，今日主力资金流出7.97亿元，成分股7只上涨，36只下跌。 序号代码名称最新价涨跌幅主力净流入主力净占比1603108润达医疗19.575.12.12亿元15.64%2002044美 年健康5.31.538366.88万元11.17%3301293三博脑科51.930.58963.33万元1.41%4301201诚达药业27.68- 0.5505.89万元3.28%5000516国际医学5.41-0.73502.98万元3.93%6002172澳洋健康4.25-0.23487.96万元 2.51%7688246嘉和美康37.48-2.12448.98万元1.2%8002219新里程2.16-0.92386.77万元2.71%9603259药明 康德93.580.31305.84万元0.06%10002524光正眼科4.67-2.1171.98万元2.63% 来源：金融界 主力资金净流出居前的分别为创新医疗（1.65亿元）、昭衍新药（1.48亿元）、睿智医药（1.04亿 元）、康龙化成（9277.26万元）、爱尔眼科（8286.05万元）。 ...

Core Viewpoint - As of August 6, 2025, Innovation Medical (002173) closed at 15.88 yuan, down 2.16%, with a turnover rate of 25.49% and a trading volume of 1.0611 million hands, resulting in a transaction amount of 1.688 billion yuan [1] Group 1: Financial Performance - The company reported a main revenue of 193 million yuan for Q1 2025, a year-on-year decrease of 3.98% [3] - The net profit attributable to shareholders was -13.9374 million yuan, a year-on-year decline of 368.03% [3] - The company’s gross profit margin stood at 8.96%, significantly lower than the industry average of 34.85% [3] Group 2: Market Position and Ratios - The total market value of Innovation Medical is 7.008 billion yuan, compared to the industry average of 19.625 billion yuan, ranking 21 out of 42 in the industry [3] - The price-to-earnings ratio (P/E) is -125.7, while the industry average is 28.51 [3] - The return on equity (ROE) is -0.79%, ranking 34 out of 42 in the industry [3] Group 3: Capital Flow Analysis - On August 6, 2025, the net outflow of main funds was 165 million yuan, accounting for 9.77% of the total transaction amount [2] - Retail investors saw a net inflow of 206 million yuan, representing 12.2% of the total transaction amount [1][2] - Over the past five days, the stock has experienced fluctuations in capital flow, with notable net inflows and outflows from different investor categories [2]

8月5日，脑机接口概念热度依旧，创新医疗涨停，翔宇医疗涨超10%，爱朋医疗、倍益康、伟思医疗、 三博脑科等快速跟涨。消息面上，苹果公司正在与脑机接口公司合作开发"使用大脑信号操纵苹果设 备"的技术标准。8月4日公布的一段展示视频，首次演示了这项技术的进展。演示视频显示，一位渐冻 症患者通过脑机设备成功实现用意念控制iPad操作，并展现应用脑机接口使用"快捷指令"等操作。 本文源自：金融界 开源证券研究所表示，2025年3月脑机接口技术首次被国家医保局设立为独立收费项目，侵入式脑机接 口置入费/侵入式脑机接口取出费/非侵入式脑机接口适配费价格分别为6552/3139/966元/次，随后湖北省 医保局发布全国首个脑机接口医疗服务价格，填补脑机接口医疗服务的价格空白，有望加快落地脑机接 口落地运用。看好政策和技术共振下脑机接口投资机会。 东吴证券研究所表示，根据《脑机接口技术发展现状及未来展望》，到2030年全球脑机接口市场规模将 达到约70亿美元，2025至2030年CAGR达到16.4%，近两年脑机领域投融资也有明显增加。国内脑机市 场规模占比近年来持续提升，2023年国内脑机市场规模达到17.3亿元，占全球市 ...

Group 1: Communication Equipment - Dongxin Peace has a net buying amount of 207 million, indicating significant institutional interest with a turnover rate of 20.87% and a transaction volume of 1.8 billion [3] - The breakthrough in large-scale array technology by ZTE Corporation has secured its position in the 6G standard, contributing to a 1.75% increase in the communication equipment index [3] - Dongxin Peace, as a leader in smart cards, is deeply integrated with operators' 5G-A construction, with expectations of at least doubling its performance upon the commercial rollout of 6G [3] Group 2: Medical Services - Innovation Medical has a net buying amount of 200 million, with a 10% increase and a 25% turnover rate, indicating a robust exchange of shares [3] - The approval of the second-class certification for the Bolein brain-machine upper limb exoskeleton rehabilitation device is set to tap into the billion-dollar home rehabilitation market [3] - With over 380 million people aged 60 and above in China, the demand for rehabilitation services is expected to grow by 15% annually, positioning the company for long-term benefits despite a previous loss of 34.29 million [3] Group 3: Automation Equipment - Aerospace Science and Technology has seen foreign capital increase by 52.74 million, driven by two main factors: a recovery in orders and foreign exchange gains [3] - The company is projected to turn a profit of 12.27 million in 2024 after a loss of 14.6 million in 2023, indicating a clear turnaround strategy [3] - The push for smart vehicles by policy support is expected to enhance the company's valuation recovery [5] Group 4: Foreign Capital Adjustment - Zhongyida has attracted 49.68 million from the Shanghai Stock Connect, focusing on phosphate chemical production for new energy battery materials, showcasing a strong technical barrier [4] - Aerospace Science and Technology's foreign capital increase reflects a strategic focus on leading technologies in the automotive sector, with 76% of its revenue coming from overseas [4] - The national equipment update fund of 10 billion is now in place, with over 30% penetration in intelligent transformation [4]